A new review article discusses how artificial intelligence can predict disease trajectories and enable precision medicine strategies for inflammatory bowel disease. AI-based systems can standardize interpretation of endoscopic images, detect mucosal healing, and support recognition of dysplasia in patients with long-standing colitis.
SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeLiterature review·DateAug 11, 2026
SAMSUNG T9 Portable SSD 2TB
SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.
Researchers found that patients with inflammatory bowel disease (IBD) are at a significantly higher risk of developing psychiatric disorders, particularly depression and anxiety. The study highlights the importance of early screening and integration of psychological care into routine IBD management to improve quality of life.
SourceAmerican Gastroenterological Association·JournalClinical Gastroenterology and Hepatology·DateAug 5, 2026
Researchers identified unique antibody signatures against viruses and bacteria in nearly 2,000 blood samples collected over a decade, showing immune system changes years before diagnosis. The study supports the theory of molecular mimicry and provides an important framework for understanding IBD's earliest stages.
SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalGut·DateJul 22, 2026
A new study found that beef protein worsens gut inflammation in mice with IBD, while pea protein shows protective effects. The research suggests that dietary protein source plays a key role in shaping gut health.
SourceAmerican Gastroenterological Association·JournalCellular and Molecular Gastroenterology and Hepatology·DateJun 24, 2026
A team of researchers has identified a distinct blood protein pattern that can accurately diagnose pediatric inflammatory bowel disease and differentiate between its two main forms. The discovery, using proteomics technology, showed high accuracy in identifying IBD and distinguishing ulcerative colitis from Crohn's disease.
SourceMass General Brigham·JournalEBioMedicine·TypeSystematic review·DateJun 23, 2026
Davis Instruments Vantage Pro2 Weather Station
Davis Instruments Vantage Pro2 Weather Station offers research-grade local weather data for networked stations, campuses, and community observatories.
Researchers discovered Paneth cell metaplasia can act as a protective response in ulcerative colitis by promoting healing and regeneration of the intestinal lining through REG3A. However, persistent changes may still carry risks, including increased cancer risk.
SourceInstitute of Science Tokyo·JournalNature Communications·TypeExperimental study·DateJun 22, 2026
Researchers have developed a new combination therapy that shows promising results in treating patients with Crohn's disease and ulcerative colitis. The treatment, which combines two mechanisms of action, has been shown to improve clinical remission rates by more than 20 percentage points compared to existing therapies.
Researchers have identified three previously unknown genotypes of Helicobacter bacteria in pygmy sperm whales stranded along the southeastern US coast. The discovery raises new questions about microbial pathogens on ocean health and their impact on vulnerable species.
SourceFlorida Atlantic University·JournalJournal of Wildlife Diseases·TypeMeta-analysis·DateFeb 19, 2026
Researchers found that mice without the ANGPTL4 gene were protected from intestinal inflammation and colon tumors due to altered macrophage behavior. The study suggests that early-life inflammatory events can shape long-term immune programming, providing resistance to future challenges.
SourceElsevier·JournalAmerican Journal Of Pathology·TypeExperimental study·DateFeb 18, 2026
Insilico Medicine presents three abstracts at the 2026 Crohn's & Colitis Congress highlighting clinical, preclinical safety, and efficacy data for ISM5411. The first-in-human Phase 1 results show no serious adverse events or deaths reported, with a favorable pharmacokinetic profile supporting gut restriction.
Apple iPhone 17 Pro
Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.
A new international study found significant changes in gut bacteria at the onset of inflammatory bowel disease (IBD), a condition that affects the digestive system. The study reveals a loss of beneficial anaerobic bacteria and an increase in oxygen-tolerant bacteria, which may trigger inflammation.
SourceUniversity of Birmingham·JournalGastroenterology·DateDec 23, 2025
The Algae for Health in Food and Pharma summit explores the latest developments in algae cultivation and processing, food innovation, and pharmaceutical applications. The event aims to advance the understanding of algae's health potential and highlight its applications across the food and pharmaceutical sectors.
SourceEuropean Science Communication Institute gGmbH·DateDec 16, 2025
Researchers discovered a new enzyme produced by Bacteroides fragilis that activates pain signaling. The enzyme is targeted with nanoparticles to develop treatments for gut pain in inflammatory bowel disease and irritable bowel syndrome. The studies aim to restore balance between good and bad bacteria to reduce symptoms.
SourceNew York University·JournalProceedings of the National Academy of Sciences·DateOct 7, 2025
Apple AirPods Pro (2nd Generation, USB-C)
Apple AirPods Pro (2nd Generation, USB-C) provide clear calls and strong noise reduction for interviews, conferences, and noisy field environments.
The Crohn's & Colitis Foundation has launched GLIDE, an integrated global registry to connect patient data from IBD registries worldwide. This initiative aims to accelerate insights into complex clinical questions, driving improvements in care for those living with Crohn's disease and ulcerative colitis.
SourceCrohn's & Colitis Foundation of America·TypeNews article·DateSep 22, 2025
A new study published in Molecular Nutrition and Food Research found that red meat consumption causes an imbalance of bacteria in the intestinal microbiota, leading to exacerbated colonic inflammation. The diets resulted in a decrease in beneficial bacterial strains and an increase in pro-inflammatory cells.
SourceWiley·JournalMolecular Nutrition & Food Research·DateAug 20, 2025
Researchers at ETH Zurich and Stanford University quantified the number of molecules produced by gut bacteria that reach the human body daily. This knowledge helps understand how the gut microbiome influences health and behavior.
SourceETH Zurich·JournalCell·TypeData/statistical analysis·DateJul 30, 2025
Researchers discovered pyruvate's ability to block TNFα/NF-κB signaling and directly target cytosolic phospholipase A2 (cPLA2), revealing a novel mechanism of action. This finding positions pyruvate as a unique, multifunctional therapeutic candidate for ulcerative colitis and potentially other inflammatory diseases.
SourceChongqing Medical University·JournalGenes & Diseases·DateJul 29, 2025
A study by University of California, Riverside researchers found that inhaling agricultural dust can alter the gut microbiome and impair intestinal function, leading to increased 'leaky gut' and associated chronic diseases. The study highlights the need for protective measures for agricultural workers.
SourceUniversity of California - Riverside·JournalJournal of Applied Toxicology·TypeExperimental study·DateJul 18, 2025
Kestrel 3000 Pocket Weather Meter
Kestrel 3000 Pocket Weather Meter measures wind, temperature, and humidity in real time for site assessments, aviation checks, and safety briefings.
A large-scale study found no association between medication use and the development of microscopic colitis, contradicting previous findings. SSRIs were linked to a slightly higher risk, but also increased the likelihood of receiving a colonoscopy.
SourceBrigham and Women's Hospital·JournalAnnals of Internal Medicine·DateJun 30, 2025
A study has discovered a connection between ferroptosis, a type of iron-dependent cell death, and inflammatory bowel disease. Lipid ROS activate ferroptosis, which drives cell death in the colon lining, and inhibiting this process may lead to new treatment options for IBD.
SourceMichigan Medicine - University of Michigan·JournalNature Metabolism·DateJun 26, 2025
Researchers have discovered that supplementing with isobutyrate eases intestinal inflammation and restores gut balance in a pig model of colitis. The study shows that isobutyrate shifts the microbiome toward beneficial bacteria, reduces diarrhea and bleeding, and strengthens the intestinal barrier.
SourceResearch·JournalResearch·TypeNews article·DateJun 25, 2025
Damage to the intestinal barrier is a key factor in IBD pathogenesis. The barrier maintains homeostasis by preventing harmful substances from entering systemic circulation. Emerging therapeutic strategies target oxidative stress modulation, microbiota restoration, and autophagy regulation.
SourceXia & He Publishing Inc.·JournalJournal of Translational Gastroenterology·DateJun 25, 2025
Microscopic colitis is a chronic inflammatory condition characterized by watery diarrhea and distinctive histologic features. The two primary subtypes are collagenous colitis and lymphocytic colitis, with collagenous colitis showing a stronger female predominance.
SourceXia & He Publishing Inc.·JournalJournal of Translational Gastroenterology·DateJun 23, 2025
Celestron NexStar 8SE Computerized Telescope
Celestron NexStar 8SE Computerized Telescope combines portable Schmidt-Cassegrain optics with GoTo pointing for outreach nights and field campaigns.
A pioneering research brings psychedelic medicine into gastroenterology, exploring psilocybin's effects on treatment-resistant irritable bowel syndrome (IBS). Dr. Erin E. Mauney's study modulates interoception and uses integrated therapy sessions with neuroimaging to track brain changes.
SourceGenomic Press·JournalPsychedelics·TypeNews article·DateJun 3, 2025
A global study describes four distinct stages of inflammatory bowel disease (IBD) as it spreads to newly developing regions in Africa, Asia, and Latin America. The research provides resources and guidance for local healthcare systems coping with the growing burden of IBD patients.
SourceUniversity of Chicago·JournalNature·TypeData/statistical analysis·DateMay 28, 2025
Researchers find inhibiting TMEM219 signaling restores mucosal healing in inflammatory bowel diseases and protects intestinal stem cells from death. The study suggests TMEM219 overactivation induces intestinal stem cell death, preventing mucosal renewal during inflammation.
SourceBoston Children's Hospital·JournalJournal of Clinical Investigation·DateMay 15, 2025
Researchers from UCalgary and Chinese University of Hong Kong found that IBD progresses through four predictable epidemiological stages as it spreads globally. The study forecasts a major rise in IBD prevalence in Canada by 2045, with countries in North America, Europe, and Oceania reaching Stage 3 (compounding prevalence). Developing ...
SourceUniversity of Calgary·JournalNature·TypeMeta-analysis·DateApr 30, 2025
Repeated esophagogastroduodenoscopy and colonoscopy enhance lesion detection, particularly in cases with active bleeding or poor visualization. The diagnostic accuracy of these procedures increases patient outcomes.
SourceXia & He Publishing Inc.·JournalJournal of Translational Gastroenterology·DateMar 11, 2025
Meta Quest 3 512GB
Meta Quest 3 512GB enables immersive mission planning, terrain rehearsal, and interactive STEM demos with high-resolution mixed-reality experiences.
A new study published in the Journal of Crohn's and Colitis reveals that vancomycin may be an effective treatment for people with inflammatory bowel disease (IBD) and autoimmune liver disease. The antibiotic achieved clinical remission in 80% of patients, with significant decreases in inflammatory markers and mucosal healing.
SourceUniversity of Birmingham·TypeExperimental study·DateFeb 10, 2025
Crohn's & Colitis Congress showcases cutting-edge research on IBD treatment barriers, genetic factors, and cardiovascular safety. Key studies reveal significant financial sacrifices made by patients to access care and identify epigenetic clues for Crohn's disease development.
SourceAmerican Gastroenterological Association·DateFeb 6, 2025
Scientists at Tel Aviv University successfully transport mRNA-based drugs to the immune system of small and large intestines without passing through the liver. The breakthrough could enable treatments for inflammatory diseases such as Crohn's and colitis.
SourceTel-Aviv University·JournalAdvanced Science·DateJan 29, 2025
Researchers have reviewed the therapeutic potential of extracellular vesicles derived from mesenchymal stem cells in treating inflammatory bowel disease. The study highlights the immunomodulatory, pro-regenerative, and anti-apoptotic properties of these vesicles, which may offer a safer alternative to conventional therapies.
SourceGermans Trias i Pujol Research Institute·JournalClinical and Translational Medicine·TypeLiterature review·DateNov 20, 2024
The American Gastroenterological Association (AGA) has released a new clinical guideline on the pharmacological management of moderate-to-severe ulcerative colitis. The guideline groups available treatments into 'efficacy buckets' to facilitate personalized treatment planning, taking into account patient risk factors and disease severity.
SourceAmerican Gastroenterological Association·JournalGastroenterology·DateNov 19, 2024
GQ GMC-500Plus Geiger Counter
GQ GMC-500Plus Geiger Counter logs beta, gamma, and X-ray levels for environmental monitoring, training labs, and safety demonstrations.
A study published in Food Innovation and Advances found that M3G supplementation improved colonic mucosal barrier function, reducing inflammation and increasing physical barrier strength. The compound inhibited the over-activation of the Notch signaling pathway, suggesting its potential therapeutic application for intestinal health.
SourceMaximum Academic Press·JournalFood Innovation and Advances·TypeExperimental study·DateSep 25, 2024
Researchers from USTC identified a causal link between microbial regulation and colitis exacerbation, proposing a treatment approach by blocking the enterococcus-tyramine-ADRA2A axis. This study provides new ways for treating inflammatory bowel disease.
SourceChinese Academy of Sciences Headquarters·JournalCell Host & Microbe·DateMay 23, 2024
A groundbreaking IBD study aims to identify biomarkers for personalized treatment, monitoring, and prediction. Researchers will collect genomic data from 1,000 newly diagnosed patients in the UK over four years.
The study reveals that 5S-Heudelotinone regulates the immune system by reducing pro-inflammatory immune cell numbers, maintaining intestinal mucosal integrity by modulating tight junctions. It also increases short-chain fatty acids and alters gut microbiota diversity, highlighting its potential as a novel treatment for IBD and CAC.
SourceCompuscript Ltd·JournalActa Pharmaceutica Sinica B·DateMay 15, 2024
Research suggests that microbes in the human gut influence social behavior, with certain bacteria offering protection against intestinal problems. The study found specific species of Blautia and Bacteroides uniformis that may benefit people with autism and GI disorders.
SourceUniversity of Utah Health·JournalNature Communications·TypeExperimental study·DateMay 13, 2024
CalDigit TS4 Thunderbolt 4 Dock
CalDigit TS4 Thunderbolt 4 Dock simplifies serious desks with 18 ports for high-speed storage, monitors, and instruments across Mac and PC setups.
Researchers revealed the biological mechanisms by which class II HDACs activate Th17 cell differentiation, leading to inflammation. A potent inhibitor, TMP269, was found to influence Th17 cell differentiation in a mouse model of ulcerative colitis, providing potential therapeutic approach for IBD treatment.
SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalProceedings of the National Academy of Sciences·DateApr 22, 2024
A new study using spatial transcriptomics has generated a unique spatial atlas of intestinal cells in both healthy and inflamed states. The research reveals the evolution of cell populations during inflammation, particularly highlighting the significance of fibroblasts in response to gut inflammation.
SourceBrigham and Women's Hospital·JournalCell·TypeExperimental study·DateApr 2, 2024
Researchers at MBL have found a genetic arrangement that confers antibiotic resistance to the bacterium Bacteroides fragilis, which may help it protect itself from tetracycline. The study highlights the role of transposons in horizontal gene transfer and potential mechanisms for controlling gene expression.
SourceMarine Biological Laboratory·JournalmBio·TypeData/statistical analysis·DateMar 1, 2024
AmScope B120C-5M Compound Microscope
AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.
The American Gastroenterological Association has proposed a 12-point plan to enhance IBD care in the US, focusing on insurer-mandated barriers such as prior authorization and step therapy. The plan aims to improve treatment access and quality for over three million Americans living with IBD.
SourceAmerican Gastroenterological Association·JournalClinical Gastroenterology and Hepatology·TypeSystematic review·DateFeb 28, 2024
Researchers at University of Tsukuba discovered a correlation between hypoxia levels and clinical symptoms in UC patients. Lower oxygen saturation in the rectal mucosa was associated with greater severity of colitis, making this method a potential tool for objective measurement of disease activity.
SourceUniversity of Tsukuba·JournalGastrointestinal Endoscopy·DateJan 23, 2024
Cancer immunotherapy can cause severe colitis due to hyper-activated immune T cells and deleted regulatory T cells. Researchers at Michigan Medicine have identified a new mouse model that develops colitis after treatment with antibodies used for tumor immunotherapy, revealing the mechanism behind this side effect.
SourceMichigan Medicine - University of Michigan·JournalScience·TypeExperimental study·DateJan 5, 2024
Apple MacBook Pro 14-inch (M4 Pro)
Apple MacBook Pro 14-inch (M4 Pro) powers local ML workloads, large datasets, and multi-display analysis for field and lab teams.
A new study finds that 10% of patients with microscopic colitis are unaware of their diagnosis, while 15% of those without the condition were unsure or thought they had it. Despite this, many cases remain symptomatic and undertreated, emphasizing the importance of follow-up appointments and education.
SourceUniversity of North Carolina Health Care·JournalGastro Hep Advances·TypeObservational study·DateDec 13, 2023
Researchers have developed a new method, SECRE, to identify genetic regulators of cytokine secretion in autoimmune diseases. The technique has been validated on cells known to play a crucial role in inflammatory bowel disease (IBD) and shows promising results for treating conditions with few therapeutic options.
SourceUniversity of Plymouth·TypeExperimental study·DateNov 27, 2023
A study published in mSystems found that mice fed a broccoli sprout diet had milder disease symptoms and richer gut microbial communities compared to those not exposed. The researchers suggest that broccoli sprouts could be used as a treatment strategy for patients with IBD.
SourceAmerican Society for Microbiology·JournalmSystems·DateNov 9, 2023
Researchers have characterised a specialised type of immune cell that plays a key role in protecting and repairing the healthy human gut. Depletion of these cells is linked to inflammatory bowel disease (IBD) progression, with potential implications for treatment options.
SourceThe Francis Crick Institute·JournalScience·TypeObservational study·DateSep 14, 2023
Fluke 87V Industrial Digital Multimeter
Fluke 87V Industrial Digital Multimeter is a trusted meter for precise measurements during instrument integration, repairs, and field diagnostics.
Nearly 70% of adolescents and young adults with ulcerative colitis discontinue treatment within a year of diagnosis, putting them at risk of disease relapse. The study highlights the need for active follow-up by GPs to monitor medication adherence and affordability.
SourceImperial College London·JournalBritish Journal of General Practice·DateSep 12, 2023
Researchers developed a platform that allows engineered biosensor bacteria to safely pass through the gastrointestinal tract in animal models. The platform enables real-time monitoring of gut health and can be used to diagnose and monitor various diseases, including inflammatory bowel disease. It has the potential to revolutionize pati...
SourceRice University·JournalBiomaterials·TypeExperimental study·DateAug 16, 2023
Researchers found that a diet high in soybean oil decreases beneficial bacteria and increases harmful bacteria, leading to increased inflammation and susceptibility to colitis. Olive oil, with lower amounts of linoleic acid, is considered a healthier alternative.
SourceUniversity of California - Riverside·JournalGut Microbes·TypeExperimental study·DateJul 5, 2023
A UNIGE team has developed small beads encapsulating fecal bacteria for treating a serious intestinal infection. The technology overcomes obstacles in current treatments, allowing for easier and more comfortable administration.
SourceUniversité de Genève·JournalInternational Journal of Pharmaceutics·TypeNews article·DateMay 9, 2023
Garmin GPSMAP 67i with inReach
Garmin GPSMAP 67i with inReach provides rugged GNSS navigation, satellite messaging, and SOS for backcountry geology and climate field teams.
A new study by Oxford researchers has found vedolizumab to be effective in inducing remission in patients with chronic pouchitis after surgery for ulcerative colitis. The treatment improved remission rates and quality of life, making it a game-changer for these patients.
SourceUniversity of Oxford·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateMar 31, 2023
A study published in iScience reveals that fibroblasts cooperate with myeloid cells to produce IL-11, protecting the mucosal epithelium from damage during acute colitis. The interaction between fibroblasts and myeloid cells is crucial for maintaining intestinal homeostasis.
SourceToho University·JournaliScience·TypeExperimental study·DateJan 17, 2023
Researchers have isolated two new bacterial species from patients with inflammatory bowel disease (IBD), which break down the protective mucus layer of the gut. The bacteria, Allobaculum mucilyticum and Allobaculum fili, are highly efficient at degrading intestinal mucus, leading to potent immune responses.
SourceUniversity Medical Center Utrecht·JournalINTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY·TypeExperimental study·DateJan 12, 2023
Salk scientists have developed a new therapeutic compound called FexD, which reverses gut inflammation in mouse models of inflammatory bowel disease. By activating the master regulator protein FXR, FexD reduces inflammation and restores balance to the digestive system.
SourceSalk Institute·JournalProceedings of the National Academy of Sciences·DateDec 12, 2022
A new study reveals that pain neurons in mice regulate mucus production and stimulate intestinal cells to release more mucus during inflammation. This protective mechanism helps maintain gut homeostasis and prevent colitis.
SourceHarvard Medical School·JournalCell·TypeExperimental study·DateOct 14, 2022
Rigol DP832 Triple-Output Bench Power Supply
Rigol DP832 Triple-Output Bench Power Supply powers sensors, microcontrollers, and test circuits with programmable rails and stable outputs.
Researchers found that certain types of dietary fiber cause inflammation in IBD patients, worsening symptoms. A stool test is being developed to predict individual responses to dietary fibers, enabling tailored recommendations.
SourceUniversity of Alberta·JournalGastroenterology·DateOct 13, 2022
A study published in Frontiers in Immunology found that Japanese herbal medicine DKT reduces colitis severity by preventing gut bacteria loss and increasing immune cells. It restores Lactobacillus levels and promotes type 3 innate lymphoid cells, alleviating inflammatory responses.
Researchers developed an AI system that classifies IBDN lesions accurately, displaying image-based diagnostic ability with 64.5% sensitivity and 89.5% specificity. The correct diagnosis rate of the AI system was 79.0, surpassing that of endoscopists, who achieved a 77.8% accuracy rate.
SourceOkayama University·JournalJournal of Gastroenterology and Hepatology·TypeComputational simulation/modeling·DateJul 13, 2022